オプションチェーンは、ZipRecruiterの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、ZipRecruiterの市場センチメントを評価します。.

ZipRecruiter (NYSE:ZIP) 株価情報, オプションチェーン

ZipRecruiter

ZipRecruiter Inc is an online employment marketplace. It connects millions of job seekers with companies of all sizes. It is a two-sided marketplace for work that simplifies the job market for both job seekers and employers. Unlike traditional online job sites, ZipRecruiter works like a matchmaker curating job opportunities for job seekers, and candidates for employers.

ZipRecruiter Inc

Ziplink Inc

STKd 100% UBER & 100% TSLA ETF

Zip Co Ltd

Zipmex - United States Dollar

JP Morgan analyst Doug Anmuth maintains ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) with a Neutral and lowers the price target from $8 to $7.

News

Price Target

Analyst Ratings

JP Morgan Maintains Neutral on ZipRecruiter, Lowers Price Target to $7

Barclays analyst Trevor Young downgrades ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) from Overweight to Equal-Weight and lowers the price target from $10 to $6.

Downgrades

Barclays Downgrades ZipRecruiter to Equal-Weight, Lowers Price Target to $6

JP Morgan analyst Neeraj S Kookada reiterated the Neutral rating on ZipRecruiter, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>), lowering the <a target="_blank" href="https://www.benzinga.com/quote/ZIP/analyst-ratings" rel="noreferrer noopener">price forecast to $8 from $9.</a>
Yesterday, the company reported fourth-quarter results, with quarterly sales of $111 million, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43956515/ziprecruiter-announces-fourth-quarter-and-full-year-2024-results" rel="noreferrer noopener">outpacing the street view of $107.73 million</a>.
ZipRecruiter expects first-quarter revenue between $107 million and $111 million and aims for year-over-year revenue growth by the fourth quarter of 2025 if hiring activity improves.
The analyst notes that ZipRecruiter is facing macro pressures and cautious employer hiring, impacting its top-line growth.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43973370/lowes-q4-win-higher-profits-big-buybacks-and-a-cautious-2025-outlook" rel="noreferrer noopener">Lowe's Q4 Win: Higher Profits, Big Buybacks And A Cautious 2025 Outlook</a>
After 28 months of year-over-year hiring declines in the U.S., ZipRecruiter is cautiously optimistic about 2025, as positive trends in employer sentiment and account reactivations suggest a potential labor market recovery, the analyst writes.
Long-term benefits are expected from investments like Phil, the personalized AI recruiter, and the shift to online recruitment, Kookada writes.
As a third player in the U.S. online recruiting market, the analyst seeks faster growth (over 20%) and improved adjusted EBITDA margins, targeting 30% in the long run.
Additionally, expanding ZipRecruiter's reach to capture more of the recruitment market is crucial.
Therefore, the analyst sees the risk-reward as balanced at current levels.
Kookada revises fiscal year 2025 and fiscal year 2026 revenue projections to $456 million (down 4% year-over-year) and $487 million (up 7% year-over-year), increasing forecasts by around 3% each.
The analyst is optimistic about positive quarter-to-date trends, product improvements, and job seeker market share gains, with total web traffic growing 15% year-over-year, outpacing peers by over 10%.
However, Kookada remains neutral due to ongoing demand challenges and macroeconomic uncertainty.
Price Action: ZIP shares are trading lower by 17.20% to $5.57 at last check Wednesday.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/02/43986471/novo-nordisks-ozempic-and-wegovy-no-longer-on-fda-shortage-list-faces-lawsuit-over-decision" target="_blank" rel="noreferrer noopener">Novo Nordisk's Ozempic And Wegovy No Longer on FDA Shortage List, Faces Lawsuit Over Decision</a></li>
</ul>

Analyst Color

Equities

Markets

Movers

Trading Ideas

General

ZipRecruiter Sees Positive Trends For 2025, But JP Morgan Cuts Price Forecast Amid Ongoing Macroeconomic Challenges

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>UBS cut Henry Schein, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSIC#NASDAQ">HSIC</a>) price target from $83 to $80. UBS analyst Kevin Caliendo maintained a Neutral rating. Henry Schein shares closed at $75.82 on Tuesday. See how other <a href="https://www.benzinga.com/quote/CRWD/analyst-ratings">analysts view this stock</a>.</li>
<li>Piper Sandler raised the price target for Prothena Corporation plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTA#NASDAQ">PRTA</a>) from $94 to $110. Piper Sandler analyst Yasmeen Rahimi maintained an Overweight rating. Prothena shares closed at $14.63 on Tuesday. <a href="https://www.benzinga.com/quote/PRTA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Canaccord Genuity increased ZoomInfo Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NASDAQ">ZI</a>) price target from $14 to $15. Canaccord Genuity analyst David Hynes maintained a Buy rating. ZoomInfo shares closed at $9.53 on Tuesday. <a href="https://www.benzinga.com/quote/CRWD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Goldman Sachs cut the price target for ZipRecruiter, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) from $9 to $8. Goldman Sachs analyst Eric Sheridan maintained a Neutral rating. ZipRecruiter shares closed at $6.73 on Tuesday. <a href="https://www.benzinga.com/quote/ZIP/analyst-ratings">See how other analysts view this stock.</a></li>
<li>RBC Capital raised the price target for agilon health, inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) from $3 to $3.5. RBC Capital analyst Sean Dodge maintained an Outperform rating. agilon health shares closed at $3.63 on Tuesday. See how other analysts <a href="https://www.benzinga.com/quote/AGL/analyst-ratings">view this stock</a>.</li>
<li>Roth MKM cut Shoals Technologies Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) price target from $5 to $4.5. Roth MKM analyst Philip Shen maintained a Neutral rating. Shoals Technologies Sports shares settled at $4.2650 on Tuesday. <a href="https://www.benzinga.com/quote/SHLS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer slashed Maplebear Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) price target from $65 to $60. Oppenheimer analyst Jason Helfstein maintained an Outperform rating. Maplebear Brands shares closed at $48.78 on Tuesday. <a href="https://www.benzinga.com/quote/CART/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho raised Check Point Software Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) price target from $220 to $230. Mizuho analyst Gregg Moskowitz maintained a Neutral rating. Check Point Software shares closed at $218.63 on Tuesday.  <a href="https://www.benzinga.com/quote/CHKP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan increased the price target for Jazz Pharmaceuticals plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAZZ#NASDAQ">JAZZ</a>) from $200 to $209. JP Morgan analyst Jessica Fye maintained an Overweight rating. Jazz Pharmaceuticals shares settled at $139.67 on Tuesday. <a href="https://www.benzinga.com/quote/JAZZ/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS increased CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) price target from $396 to $450. UBS analyst Roger Boyd maintained a Buy rating. CrowdStrike shares closed at $379.75 on Tuesday. <a href="https://www.benzinga.com/quote/CRWD/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43981181/nvidia-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">Nvidia Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

CART

CHKP

CRWD

HSIC

JAZZ

PRTA

SHLS

CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday

UBS analyst Kunal Madhukar maintains ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) with a Neutral and lowers the price target from $11 to $7.

UBS Maintains Neutral on ZipRecruiter, Lowers Price Target to $7

Goldman Sachs analyst Eric Sheridan maintains ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) with a Neutral and lowers the price target from $9 to $8.

Goldman Sachs Maintains Neutral on ZipRecruiter, Lowers Price Target to $8

JP Morgan analyst Doug Anmuth maintains ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) with a Neutral and lowers the price target from $9 to $8.

JP Morgan Maintains Neutral on ZipRecruiter, Lowers Price Target to $8

ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) reported quarterly sales of $111.000 million which beat the analyst consensus estimate of $107.835 million by 2.93 percent. This is a 18.34 percent decrease over sales of $135.922 million the same period last year.

Earnings

Earnings Beats

ZipRecruiter Q4 Sales $111.000M Beat $107.835M Estimate

AHCO

ALLT

ARQT

AXGN

AXON

BASE

BGFV

BLZE

BTDR

BWIN

CAVA

CBLL

CCCS

CECO

CGBD

CHRD

CIFR

CPNG

CPSS

DAWN

DNUT

DOCN

DRVN

ELAN

EXLS

FIHL

FLYW

FSLR

FULC

GPOR

HRMY

HURN

HYLN

IART

ICCC

IGIC

IMOS

INGN

INTU

INVX

IPAR

ITRI

IVAC

JACK

KEYS

KNSA

LCID

LGIH

LIVN

LMND

LXFR

MASI

MATX

MFIC

MIDD

MMSI

MPLN

MRVI

NOVT

NXRT

Earnings Scheduled For February 25, 2025

Doctors are ditching the hospital grind for corporate boardrooms. And with $275,000 salaries, better hours, and less stress, it's easy to see why.
The rise of chief medical officers in tech, startups, and even companies like Google and Salesforce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NASDAQ">CRM</a>) is pulling more doctors away from clinical roles. They're trading 12-hour shifts for leadership positions that still <a href="https://www.benzinga.com/partner/health-care/25/01/42901251/the-silent-revenue-killer-in-us-healthcare-and-the-tech-that-is-fighting-back">impact healthcare</a>—just on a bigger scale.
Why Doctors Are Making the Switch
For Dr. Lisa Shah, the shift was about scale. She loved treating patients but left exhausted every day. Losing them took a toll.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>
Now, as CMO at Twin Health, a health tech startup using AI to monitor metabolism, she's helping treat populations instead of just one patient at a time.
&#8220;We&#8217;re seeing a lot of chief medical officers coming on board to grant that clinical, medical legitimacy to whatever products people are developing,&#8221; Chris Myers, a Johns Hopkins professor, told Business Insider.
The COVID-19 pandemic only accelerated the trend. Burnout soared. A Bain &amp; Company survey found that one in four clinicians were considering leaving medicine.
And the pay? Still solid. ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) says CMOs earn around $275,000 per year—comparable with a doctor's salary but without the brutal hours.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
A Growing Trend in Health Tech
Health tech is booming. It's expected to hit $1.5 trillion by 2032, growing at nearly 19% per year, <a href="https://rockhealth.com/insights/2023-q1-digital-health-funding-investing-like-its-2019/">according to researchers at Rock Health</a>.&nbsp;
That means more companies need medical expertise—and they're hiring doctors to provide it.
Dr. Guy Maytal spent nearly two decades in psychiatry before joining Forge Health, a startup focused on mental health and substance use treatment.
"I could grumble on the sidelines, or roll up my sleeves and do something about it," he told Business Insider.
Trending: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a>
The Role of CMOs in Business
Tech giants are getting in on the action. <a href="https://www.benzinga.com/markets/25/02/43616463/salesforce-and-aws-pledge-500m-to-boost-ai-development-in-saudi-arabia">Salesforce</a> hired a CMO in 2019 to focus on employee health. Google added its first chief health officer the same year.
At Uber Health, Dr. Joshua Sclar now works on getting patients to medical appointments and delivering medications.
&#8220;Being a physician, I know what happens when that care is missed,&#8221; he told Business Insider.
But adjusting to corporate life isn't always easy. Dr. Nikole Benders-Hadi, CMO at TalkSpace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TALK#NASDAQ">TALK</a>), says her biggest challenge was learning to communicate with business leaders who don't speak &#8220;doctor.&#8221;
&#8220;There can be really different end goals when you&#8217;re talking about business objectives versus healthcare objectives,&#8221; she said.
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
A Lifeline for Overworked Doctors?
For doctors used to on-call shifts, patient loss, and insurance battles, moving to a CMO role reduces emotional toll.
"These jobs seem stressful, but they're not life and death," said Dr. Jonathan Jaffery of the Association of American Medical Colleges.
And while America faces a shortage of 86,000 physicians by 2036, many believe CMOs aren't the problem—they're part of the solution.
Dr. Nate Favini, CMO of Pair Team, a startup connecting Medicaid patients to care, thinks technology will help fix the system.
"There's a massive opportunity to harness tech to deliver better care at a fraction of the cost," he told Business Insider.
Doctors aren't just leaving medicine. They're changing it.
Read Next:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

TALK

From $275,000 Salaries To Work-Life Balance: Why Burned-Out Doctors Are Trading The ER For The C-Suite

UBS analyst Kunal Madhukar maintains ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) with a Neutral and raises the price target from $7.5 to $11.

UBS Maintains Neutral on ZipRecruiter, Raises Price Target to $11

ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.09) by 66.67 percent. The company reported quarterly sales of $117.084 million which beat the analyst consensus estimate of $112.612 million by 3.97 percent. This is a 24.77 percent decrease over sales of $155.630 million the same period last year.

ZipRecruiter Q3 2024 GAAP EPS $(0.03) Beats $(0.09) Estimate, Sales $117.084M Beat $112.612M Estimate

ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) sees Q4 sales of $104.000 million-110.000 million vs $108.45 million estimate.

Guidance

ZipRecruiter Sees Q4 Sales $104.000M-110.000M vs $108.45M Est

During the last three months, 7 analysts shared their evaluations of ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $10.07, a high estimate of $11.50, and a low estimate of $8.00. Highlighting a 19.44% decrease, the current average has fallen from the previous average price target of $12.50. 
<img src="https://www.benzinga.com/files/images/story/2024/1723230024_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of ZipRecruiter by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eric Sheridan</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$8.00</td>
<td>$11.50</td>
</tr>
<tr>
<td>Trevor Young</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$10.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Doug Anmuth</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$9.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Mark Mahaney</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$11.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Doug Anmuth</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$10.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Kunal Madhukar</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$11.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Eric Sheridan</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$11.50</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to ZipRecruiter. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of ZipRecruiter compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of ZipRecruiter's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into ZipRecruiter's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ZIP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on ZipRecruiter analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>All You Need to Know About ZipRecruiter</h2>
ZipRecruiter Inc is an online employment marketplace. It was founded to make meaningful connections between job seekers and employers. It connects millions of job seekers with companies of all sizes. It is a two-sided marketplace for work that simplifies the job market for both job seekers and employers. Unlike traditional online job sites, ZipRecruiter works like a matchmaker curating job opportunities for job seekers, and candidates for employers.
<h3>Unraveling the Financial Story of ZipRecruiter</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: ZipRecruiter's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -27.44%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Communication Services sector.
Net Margin: ZipRecruiter's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 5.67%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): ZipRecruiter's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 37.83% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): ZipRecruiter's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.06%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 22.71, caution is advised due to increased financial risk.
<h2>Analyst Ratings: Simplified</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings For ZipRecruiter

Goldman Sachs analyst Eric Sheridan maintains ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) with a Neutral and lowers the price target from $11.5 to $8.

Barclays analyst Trevor Young maintains ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) with a Overweight and lowers the price target from $14 to $10.

Barclays Maintains Overweight on ZipRecruiter, Lowers Price Target to $10

JP Morgan analyst Doug Anmuth maintains ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) with a Neutral and lowers the price target from $10 to $9.

JP Morgan Maintains Neutral on ZipRecruiter, Lowers Price Target to $9

WIIM

ZipRecruiter shares are trading higher after the company reported better-than-expected Q2 financial results. Additionally, the company announced the acquisition of Breakroom.

Evercore ISI Group analyst Mark Mahaney maintains ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) with a In-Line and lowers the price target from $12 to $11.

Evercore ISI Group Maintains In-Line on ZipRecruiter, Lowers Price Target to $11

ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.07) by 200 percent. The company reported quarterly sales of $123.658 million which beat the analyst consensus estimate of $117.715 million by 5.05 percent. This is a 27.44 percent decrease over sales of $170.421 million the same period last year.

ZipRecruiter Q2 2024 GAAP EPS $0.07 Beats $(0.07) Estimate, Sales $123.658M Beat $117.715M Estimate

Press Releases

ZipRecruiter to Report Third Quarter 2024 Financial Results on November 6, 2024

ZipRecruiter Announces Third Quarter 2024 Results

ZipRecruiter and Paradox Partner to Make Hiring Fast and Frictionless

ZipRecruiter to Participate at Upcoming Investor Conferences

ZipRecruiter Study Finds U.S. Employers Have Renewed Optimism for Labor Market

ZipRecruiter to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

ZipRecruiter Announces Fourth Quarter and Full Year 2024 Results

ZipRecruiter to Participate at Upcoming Investor Conference

ZipRecruiter Named to Fast Company's Annual List of World's Most Innovative Companies

ZipRecruiter to Report First Quarter 2025 Financial Results on May 8, 2025

Angi

The Arena Group Holdings, Inc. Common Stock

Arena Group Holdings

Bumble

Cars.com

DHI Group

EverQuote

FuboTV

Getty Images Holdings, Inc. Class A Common Stock

Getty Images Holdings

Nextdoor Holdings, Inc. Class A Common Stock

Nextdoor Holdings

36Kr Holdings Inc. - American Depositary Shares

36KR Holdings

MediaAlpha

Hello Group Inc. - American Depositary Shares

Hello Gr

Outbrain

PSQ Holdings

QuinStreet

Shutterstock

So-Young International Inc. - American Depository Shares

So-Young Intl

Taboola.com

TrueCar

trivago N.V. - American Depositary Shares

trivago

Travelzoo

Vimeo

Vtex

Yalla Group Limited American Depositary Shares, each representing one Class A Ordinary Share

Yalla Group

Zhihu Inc. American Depositary Shares, each representing three (3) Class A Ordinary Shares

Comments

ZipRecruiter

ZipRecruiter (ZIP) オプション

ZipRecruiter (NYSE:ZIP) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル